Literature DB >> 23378546

Pulmonary veno-occlusive disease: an uncommon cause of pulmonary hypertension.

Kyle Masters1, Steven Bennett.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare and challenging cause of pulmonary hypertension. Clinical presentation is non-specific, including dyspnoea, cough and fatigue. Diagnosis of PVOD is typically based on high clinical suspicion with a definitive diagnosis confirmed by histology. Our case involves a healthy 21-year-old man who developed dyspnoea on exertion at an elevated altitude during deployment to Afghanistan. His work-up included an echocardiogram, a high-resolution CT scan, V/Q scan, pulmonary function tests with diffusion capacity, and a cardiac catheterisation with vasodilator challenge. Initially diagnosed with vasodilator responsive pulmonary arterial hypertension, an oral vasodilator was given with subsequent development of non-cardiogenic pulmonary oedema, thus confirming a clinical diagnosis of PVOD. He was medically stabilised with diuretic therapy, but developed progressive right-ventricular failure. For definitive treatment, he underwent a successful bilateral lung transplant. Explanted lung histology confirmed the diagnosis of PVOD.

Entities:  

Mesh:

Year:  2013        PMID: 23378546      PMCID: PMC3603636          DOI: 10.1136/bcr-2012-007752

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Pulmonary veno-occlusive disease.

Authors:  J Mandel; E J Mark; C A Hales
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

Review 2.  Pulmonary veno-occlusive disease: recent progress and current challenges.

Authors:  David Montani; Dermot S O'Callaghan; Laurent Savale; Xavier Jaïs; Azzedine Yaïci; Sophie Maitre; Peter Dorfmuller; Olivier Sitbon; Gérald Simonneau; Marc Humbert
Journal:  Respir Med       Date:  2010-04-24       Impact factor: 3.415

Review 3.  Treatment of pulmonary arterial hypertension.

Authors:  Marc Humbert; Olivier Sitbon; Gérald Simonneau
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

Review 4.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 5.  Pulmonary veno-occlusive disease: advances in clinical management and treatments.

Authors:  Alice Huertas; Barbara Girerd; Peter Dorfmuller; Dermot O'Callaghan; Marc Humbert; David Montani
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

6.  Pulmonary veno-occlusive disease: a case series and new observations.

Authors:  B W Holcomb; J E Loyd; E W Ely; J Johnson; I M Robbins
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

7.  Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation.

Authors:  Gabriel Izbicki; David Shitrit; Itzhak Schechtman; Danielle Bendayan; Gershon Fink; Gideon Sahar; Milton Saute; Tuvia Ben-Gal; Mordechai R Kramer
Journal:  J Heart Lung Transplant       Date:  2005-05       Impact factor: 10.247

Review 8.  Pulmonary veno-occlusive disease.

Authors:  S Veeraraghavan; M N Koss; O P Sharma
Journal:  Curr Opin Pulm Med       Date:  1999-09       Impact factor: 3.155

9.  Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.

Authors:  David Montani; Lara Achouh; Peter Dorfmüller; Jérôme Le Pavec; Benjamin Sztrymf; Colas Tchérakian; Anne Rabiller; Rehan Haque; Olivier Sitbon; Xavier Jaïs; Philippe Dartevelle; Sophie Maître; Frédérique Capron; Dominique Musset; Gérald Simonneau; Marc Humbert
Journal:  Medicine (Baltimore)       Date:  2008-07       Impact factor: 1.889

  9 in total
  1 in total

1.  Pulmonary veno-occlusive disease: the role of CT.

Authors:  Giangaspare Mineo; Domenico Attinà; Martina Mughetti; Caterina Balacchi; Fiorella De Luca; Fabio Niro; Federica Ciccarese; Luigi Lovato; Vincenzo Russo; Francesco Buia; Cecilia Modolon; Alessandra Manes; Massimiliano Palazzini; Nazareno Galiè; Maurizio Zompatori
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.